News & Commentary
The Surveillance Machine Moves to Defend Itself
In a pair of stories this past weekend, the Washington Post and the AP reported on the construction of an ambitious surveillance system by which the government aims to carry out detailed surveillance of its own employees.
By By Jay Stanley, Senior Policy Analyst, ACLU Speech, Privacy & Technology Project
My Employer Shamed Me for Using Birth Control
By Jessica R.
The Af
By Blog of Rights: Official Blog of the American Civil Liberties Union
Answering to the American People on Immigration
This week, Department of Homeland Security (DHS) Secretary Jeh Johnson is busy testifying before four different congressional committees on the President’s FY 2015 DHS budget request.
By By Georgeanne M. Usova, Washington Legislative Office
Federal Court Rules DOJ’s Location Tracking Memos Can Stay Secret
Yesterday, a federal district court ruled that the Justice Department does not need to disclose two secret memos providing guidance to federal prosecutors and investigators regarding the use of GPS devices and other location tracking technologies. The government had previously released the documents in response to the ACLU’s Freedom of Information Act lawsuit, but their contents were almost entirely censored. (You can view the redacted documents, in all their glory, here and here.)
By By Brian Hauss, Legal Fellow, ACLU Speech, Privacy and Technology Project
Cyberalarmism's Threat to Privacy
This piece originally ran on Al Jazeera America.
By By Michelle Richardson, Legislative Counsel, ACLU Washington Legislative Office
Myriad Genetics’ Latest Attempt to Maintain Its Monopoly on Our Genes Rejected
Last June, the U.S. Supreme Court issued a unanimous ruling invalidating patents on human genes. The case was brought by the ACLU, along with the Public Patent Foundation, on behalf of 20medical organizations, geneticists, health advocacy groups, and patients and challenged patents controlled by Myriad Genetics on the BRCA1 and BRCA2 genes. Based on a 30-year-old U.S. Patent & Trademark Office policy, Myriad had obtained its patents on these two genes, which are closely associated with hereditary breast and ovarian cancer risk, and stopped other laboratories in the U.S. from providing genetic testing to patients, even when these labs wanted to offer different, more comprehensive, or less expensive tests.
By By Sandra Park, ACLU
The Tech Community Can Put Out the Fire the NSA Started
This piece originally ran at the Guardian.
By By Chris Soghoian, Principal Technologist and Senior Policy Analyst, ACLU Speech, Privacy and Technology Project
Stay Informed
Sign up to be the first to hear about how to take action.
By completing this form, I agree to receive occasional emails per the terms of the ACLU’s privacy statement.
By completing this form, I agree to receive occasional emails per the terms of the ACLU’s privacy statement.